Connor, Clark & Lunn Investment Management (CC&L)’s Kura Oncology KURA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.9M	Buy	996,114 +195,517	+24%	+$1.84M	0.02%	514
2026 Q1	$6.51M	Buy	800,597 +182,026	+29%	+$1.56M	0.02%	609
2025 Q4	$6.43M	Buy	618,571 +253,639	+70%	+$2.66M	0.02%	578
2025 Q3	$3.23M	Buy	+364,932	New	+$2.6M	0.01%	705
2024 Q4	–	Sell	-29,655	Closed	-$579K	–	1523
2024 Q3	$579K	Buy	29,655 +7,722	+35%	+$156K	﹤0.01%	1059
2024 Q2	$452K	Buy	+21,933	New	+$451K	﹤0.01%	1079
2024 Q1	–	Sell	-18,917	Closed	-$272K	–	1622
2023 Q4	$272K	Buy	+18,917	New	+$186K	﹤0.01%	1195
2022 Q4	–	Sell	-53,240	Closed	-$727K	–	1330
2022 Q3	$727K	Buy	+53,240	New	+$821K	﹤0.01%	722

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s KURA Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its Kura Oncology (KURA) stake by 24% in Q2 2026, buying an estimated $1.84M and bringing the position to 996,114 shares worth $10.9M. The position accounts for 0.02% of the portfolio, ranked #514.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in KURA in Q3 2022 and has held it in 8 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

Connor, Clark & Lunn Investment Management (CC&L) held 996,114 shares of Kura Oncology worth $10.9M as of Q2 2026.
Connor, Clark & Lunn Investment Management (CC&L) bought 195,517 Kura Oncology shares in Q2 2026, an estimated $1.84M.
Kura Oncology made up 0.02% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #514 holding.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Kura Oncology in Q3 2022 and has held it in 8 quarters since.
220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.